7 November 2024
Ropes & Gray Advises Monte Rosa Therapeutics in Global Licensing Collaboration with Novartis
Healthcare & Life Sciences Announced
Advising firms
Deal team
4 lawyers named| Lawyer | Firm | Seniority | Practice | Office |
|---|---|---|---|---|
| David McIntosh | Ropes & Gray | Partner | life sciences licensing | Not stated |
| Marc Rubenstein | Ropes & Gray | Partner | life sciences licensing | Not stated |
| Nicole Rohr | Ropes & Gray | Associate | life sciences licensing | Not stated |
| Megan Fernandez | Ropes & Gray | Associate | life sciences licensing | Not stated |
1 more lawyer on this deal. Register free to see the full deal team, with seniority, practice and office.
REGISTER FREE SIGN INWant co-counsel patterns, repeat clients and alerts when these firms land their next deal? Get Pro.
Stated terms
- Stated value
- USD 150m ($150 million)
- What the figure measures
- Total transaction value
- Client
- Monte Rosa TherapeuticsIssuer
- Counterparties
- Novartis (Other)